Neurovascular Devices Market by Product (Embolization Devices, Revascularization Devices, Embolic Protection Devices, and Accessory Devices), Disease Pathology (Aneurysm, Arteriovenous Malformation (AVM), Ischemic Stroke, Stenosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
Neurovascular devices are defined as instruments and machines employed in treatment of various neurovascular disorders. Furthermore, neurovascular disorders include medical conditions that affect blood vessels, which supply the brain and spinal cord with oxygenated blood. Thus, neurovascular devices such as embolization devices, revascularization devices, thrombectomy devices, and embolic protection devices are used in treatment of neurovascular disorders.
These devices are used in disorders such as aneurysm. For instance, embolization devices are used in occlusion of blood vessels to reduce blood flow, which, in turn, aids in reduction of blood flow. Similarly, other neurovascular devices such as thrombectomy devices are used in disorders such as ischemic stroke. For instance, these thrombectomy devices aid in recovering the brain from ischemic condition if it has not attained the stage of complete infarction. Thus, these devices restore perfusion through blocked artery.
The major factor that contributes toward growth of the neurovascular devices market include surge in geriatric population. Furthermore, other factors such as rise in prevalence of neurovascular diseases and surge in adoption of neurovascular devices across the globe also contribute to growth of the market. In addition, factors such as surge in technological advancements related to neurovascular devices also boost growth of the neurovascular devices market.
However, high cost of neurovascular devices and dearth of qualified neurosurgeons required to handle these devices restrict growth of the market. Conversely, high growth rate exhibited by developing nations provides lucrative opportunities for players operating in the neurovascular devices market
The global neurovascular devices market is segmented on the basis of product, disease pathology, and region to provide a detailed assessment of the market. By product, the market is divided into embolization devices, revascularization device, thrombectomy devices, embolic protection devices, and accessory devices.
Moreover, these product categories are further divided into sub segments for a profound understanding. For instance, the embolization devices segment is divided into clippings, embolic coils, coil assist stents, and coil assist balloons. In addition, the embolic coils segment is further divided into bare detachable coils and coated detachable coils.
The revascularization device segment is further divided into carotid artery stents and flow diversion stents. In addition, the thrombectomy devices segment is divided into clot retrieval devices, suction & aspiration devices, and snares. The embolic protection devices segment is divided in distal filter devices and balloon occlusion devices. Similarly, the accessory devices segment is divided into microcatheters, and micro guidewires. By disease pathology, the market is classified into aneurysm, arteriovenous malformation (AVM), stenosis, ischemic stroke and others. By region, the neurovascular devices market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major players in the neurovascular devices market are Medtronic Plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc.., Integer Holdings Corporation, Acandis GmbH., W. L. Gore & Associates, Inc., and Microport Scientific Corporation.
KEY BENEFITS FOR STAKEHOLDERS • This report entails a detailed quantitative analysis along with the current global neurovascular devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
• By Disease Pathology
o Arteriovenous Malformation and Fistulas (AVM)
o Ischemic Stroke
• By Region
o North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
• List of key players profiled in the report:
• Medtronic Plc,
• Stryker Corporation
• Penumbra, Inc.
• Johnson & Johnson
• Terumo Corporation
• Merit Medical Systems, Inc.
• Integer Holdings Corporation
• Acandis GmbH
• W. L. Gore & Associates, Inc.
• Microport Scientific Corporation
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) • Asahi Intecc co., ltd.
• Kaneka Medix Corp.
• Embolx, Inc.
• Wallaby Medical
Our reports have been used by over 10K customers, including:
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC and SLM Solutions Group AG. The global 3D printed implants market is expected to grow from $0.14 billion in 2020 to $0.15 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies...
Anatomic Pathology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology types, applications. Further, Anatomic Pathology...
Anatomic Pathology Track and Trace Solutions market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anatomic Pathology Track and Trace Solutions Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anatomic Pathology...
Pathology Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pathology Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pathology Devices types, applications. Further, Pathology Devices...
The global apheresis equipment market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
The global arthroscopy devices market exhibited moderate growth during 2015-2020. Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body. They are primarily used for the treatment of medical conditions,...
129 pages •
By Global Industry Analysts
• Aug 2021
Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...
17 pages •
By Euromonitor International
• Aug 2021
Strong net migration will be the key driver of rapid population expansion in Austria in 2020-2040. Ageing will continue to accelerate, impacting consumer trends. Rapid growth in the number of foreign citizens, who will account for over a quarter of the population in 2040, will make the country increasingly diverse. At the same time, Austria...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.